|
|
Volumn 42, Issue 3, 2005, Pages 465-
|
|
Risk factors, medical therapies and perioperative events in limb salvage surgery: Observations from the PREVENT III multicenter trial - Commentary
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTILIPEMIC AGENT;
ANTITHROMBOCYTIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
EDIFOLIGIDE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
UNCLASSIFIED DRUG;
AFRICAN AMERICAN;
ATHEROSCLEROSIS;
CEREBROVASCULAR DISEASE;
CLINICAL TRIAL;
COMORBIDITY;
DRUG UTILIZATION;
GRAFT FAILURE;
GRAFT OCCLUSION;
HEART INFARCTION;
HEART PROTECTION;
HOSPITAL DISCHARGE;
HUMAN;
HYPERTENSION;
KIDNEY FAILURE;
LEG REVASCULARIZATION;
LIMB ISCHEMIA;
LIMB SALVAGE;
MORBIDITY;
NOTE;
PRIORITY JOURNAL;
RISK FACTOR;
SURGICAL MORTALITY;
SYSTEMIC DISEASE;
TREATMENT OUTCOME;
VASCULAR SURGERY;
VEIN GRAFT DISEASE;
|
|
EID: 24944537909
PISSN: 07415214
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jvs.2005.05.015 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|